In Stroke, When is a Good Outcome Good Enough?
NEJM 386:1359-1361, Schwamm, L.H., 2022
Outcomes After Endovascular Thrombectomy with or without Alteplase in Routine Clinical Practice
JAMA Neurol 79:768-776, Smith, E.E.,et al, 2022
Vaccine-Induced Thrombocytopenia with Severe Headache
NEJM 385:doi:10.1056/NEJMc2112974, Salih, F.,et al, 2021
Antiplatelet Treatment to Prevent Early Recurrent Stroke
NEJM 383:276-278, Rothwell, P.M., 2020
Impact of Microbleeds on Outcome Following Recanalization in Patients with Acute Ischemic Stroke
Stroke 50:127-134, Choi, K.H.,et al, 2019
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NEJM 378:2191-2201, Hart, R.G.,et al, 2018
Stroke
Lancet 389:641-654, Hankey, G.J., 2017
Arteriovenous Malformations of the Brain
NEJM 376:1859-1866, Solomon, R.A. & Connolly, E.S., 2017
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016
Early Start of DOAC after Ischemic Stroke
Neurol 87:1856-1862,1652, Seiffge, D.J.,et al, 2016
Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis
Medicine 93:42-52, Gonzalez, I.,et al, 2014
Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014
Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013
Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Endovascular Treatment of Brain Arteriovenous Fistulas
AJNR 30:851-856, Lv,X.,et al, 2009
Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials
Stroke 38:423-430, Paciaroni,M.,et al, 2007
Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007
Arteriovenous Malformations of the Brain
NEJM 356:2704-2712, Friedlander,R.M., 2007
Favorable Early Outcome of Carotid Artery Stenting Without Protection Devices
Stroke 35r:2862-2866, Sztriha,L.K.,et al, 2004
Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003
Recommendations for the Management of Intracranial Arteriovenous Malformations
Stroke 32:1458-1471, Ogilvy,C.S.,et al, 2001
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Arteriovenous Malformations of the Brain in Adults
NEJM 340:1812-1818, The Arteriovenous Malformation Study Group, 1999
Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Cerebrovascular Complications of Fabry's Disease
Ann Neurol 40:8-17, Mitsias,P.&Levine,S.R., 1996
Clinicopath Conf
Subacute Bacterial Endocarditis with Multiple Cerebral Emboli and Mycotic Aneurysm, Case 10-1993, NE, M 8:717-725,1993., 1993
Early Heparin Therapy in Patients with Spontaneous Intracerebral Haemorrhage
JNNP 54:466-467, Boeer,A.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Central Nervous System Complications of Infective Endocarditis
Stroke 22:1461-1463, Salgado,A.V., 1991
The Diagnosis and Treatment of Cerebral Myocotic Aneurysms
Ann Neurol 27:238-246, Brust,J.C.M.,et al, 1990
Stroke in Young Adults
Stroke 21:382-386, Bevan,H.,et al, 1990
Prosthetic Valve Endocarditis 1976-1987, Antibiotics, Anticoagulation, and Stroke
Stroke 21:993-999, Davenport,H.&Hart,R.G., 1990
Stroke in Infective Endocarditis
Stroke 21:695-700, Hart,R.G.,et al, 1990
Acute Anticoagulation Following Cardioembolic Stroke
Stroke 20:730-734, Rothrock,J.F.,et al, 1989
Hemorrhagic Transformation in Cerebral Embolism
Stroke 20:598-603, Okada,Y.,et al, 1989
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Intracerebral Hemorrhage in Stroke Patients Anticoagulated with Heparin
Stroke 20:1500-1503, Babikian,V.L.,et al, 1989
Cardioembolic Stroke
Early Anticoagulation, & Brain Hemorrhage, Cerebral Embolism Study Group, Arch Int Med 147:636-640., , 1987
Mechanisms of Intracranial Hemorrhage in Infective Endocarditis
Stroke 18:1048-1056, Hart,R.G.,et al, 1987
Anticoagulant-Related Hemorrhage in Acuit Cerebral Embolism
Stroke 15:426-437, Shields,R.W.,et al, 1984
Neurologic Manifest. of Infective Endocarditis:A Review
Stroke 4:958, Greenlee,J.E.,et al, 1973
Treatment of Strokes
NEJM 281:594, 1969,, Browne,T.,et al, 1969
Neurologic Manifestations of Bacterial Endocarditis
Ann Int Med 71:21, Jones,H.,et al, 1969
Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023